Aquestive Therapeutics (NASDAQ:AQST) Given Buy Rating at HC Wainwright
Aquestive Therapeutics (NASDAQ:AQST – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $10.00 price target on the stock. HC Wainwright’s price objective would suggest a potential upside of 278.79% from the company’s current price. HC Wainwright also issued estimates […]
Aquestive Therapeutics (NASDAQ:AQST – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $10.00 price target on the stock. HC Wainwright’s price objective would suggest a potential upside of 278.79% from the company’s current price. HC Wainwright also issued estimates […]
